Atlas Trials

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

Clinical trial NCT00121849 · COMPLETED

Trial details

NCT number
NCT00121849
Sponsor
Access to Advanced Health Institute (AAHI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cutaneous Leishmaniasis
Start date
2005-08-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.